16 Jan. 64 – Dr. Yongpoo Worawan, head of the Center of Specialization in Clinical Virology Department of Pediatrics Faculty of Medicine Chulalongkorn University Has posted a message on personal Facebook Yong Poovorawan As follows
Covid 19 vaccine
From past studies Vaccine effectiveness Will come out in the form of protection Reduce the severity of the disease
Reduce the symptoms of the disease without having to go to hospital or, if so, have the least symptoms.
Most recent studies The prevention of infection has not been studied. Or prevention of addiction without symptoms
Therefore, the vaccination now Therefore focus on reducing the severity of the disease
Who will be vaccinated at this time It is a risk group that is already suffering from severe symptoms and death.
Have to wait and see the information in the future. If the vaccine can prevent infection Even without symptoms
Immunization will focus on those who will be infected without symptoms.
But infectious Or those who are young enough
The current studies on the covid 19 vaccine are not complete and have been completed because they were needed first.
Need specific information before All details have to be analyzed. And further study in the long term
Believe that in the near future Will have new information coming out When new information comes out Vaccination strategies May change
Such as allowing a group to easily contract the disease during labor age and spread it to others
So today from the present information The group who should be vaccinated is therefore more vulnerable to severe disease than it would in the more readily spread group. Such as in a young age, a healthy labor age
– .
